Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001591 · ClinicalTrials.gov registry record

Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy

A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).

Completed
Registry status
450
Enrollment target

NCT00001591 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 450 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001591 has completed, sponsored by National Institutes of Health Clinical Center (CC).

COMPLETED
Registry status
450 participants
Enrollment target

Study Summary

Technical advances in magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) have provided researchers with the opportunity to study changes of the central nervous system (CNS) and improve diagnosis and therapy of CNS disease. New MRI and MRS techniques specifically designed for functional MRI (fMRI) and MRS imaging of the CNS will be evaluated in normal volunteers and in patients with CNS diseases. This study will develop and evaluate new magnetic resonance pulse sequences for performing MRI or MRS and compare the results to existing MR techniques. Patients and volunteers age 18 and older are eligible for the study. A history will be taken in which exclusion criteria (such as having a pacemaker or cochlear implants) will be addressed, and a pregnancy test will be administered to women of childbearing age. Each subject will also be asked to fill out a questionnaire. Study participants will lie in the MRI scanner from 20 minutes to 2 hours. A coil may be placed on the head and participants may be asked to do simple or complex tasks. A catheter will be placed in an arm vein and a contrast agent will be administered. This agent will allow structures in the brain to show up more clearly.

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 1997-07
Est. Completion 2003-07

What the Registry Record Tells You About NCT00001591

The ClinicalTrials.gov registry entry for NCT00001591 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00001591 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00001591 about?

NCT00001591 is a clinical study titled "Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy". Technical advances in magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) have provided researchers with the opportunity to study changes of the central nervous system (CNS) and improve diagnosis and therapy of CNS disease. New MRI and MRS techniques specifically designed for ...

What is the current status of trial NCT00001591?

This trial is currently completed. The enrollment target is 450 participants. The study started on 1997-07. Estimated completion is 2003-07.

Who is sponsoring clinical trial NCT00001591?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.